
Auristone bags $5.4m in Elev8.vc-led funding round
The startup will use the capital to promote its flagship product.
Auristone has secured $5.4m (US$4m) capital from its latest seed funding round led by venture capital firm Elev8.vc.
SEEDS Capital and existing investor Genedant joined the funding round.
The biotech startup focuses on promoting epigenomics in healthcare through its flagship molecular profiling test, “EPI-CALL,” which assists doctors and late-stage cancer patients navigate different therapy options.
The startup will use the raised funds to expand its clinical collaborations and promote EPI-CALL in the market by working with regional genomic companies.